Literature DB >> 6167156

Comparative effects of oxatomide on the release of histamine from rat peritoneal mast cells.

F De Clerck, J Van Reempts, M Borgers.   

Abstract

Oxatomide inhibits the release of histamine from rat peritoneal mast cells in vitro induced by C 48/80, antigen, anti-IgE and ionophore A 23 187, without effect on non-specific release by n-decylamine. Its effect is concentration- and pH-dependent and decreases with increasing extracellular Ca2+-concentrations. Prolonged incubation does not enhance the inhibition, which is lost after one single wash-out. Aminophylline and isoproterenol are not potentiated by oxatomide. The present study points to an effect of oxatomide on a Ca2+-dependent process at the level of cell membrane common to antigen, C 48/80 and ionophore A 23 187.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6167156     DOI: 10.1007/BF01967612

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  39 in total

1.  Refinements in the automated fluorometric histamine analysis system.

Authors:  R P Siraganian
Journal:  J Immunol Methods       Date:  1975-06       Impact factor: 2.303

2.  CYTOTOXIC TEST FOR DEMONSTRATION OF MOUSE ANTIBODY.

Authors:  E A BOYSE; L J OLD; I CHOUROULINKOV
Journal:  Methods Med Res       Date:  1964

3.  Inhibition and stimulation of histamine release by oxatomide.

Authors:  C W Bierman; E S Assem; J L Mongar
Journal:  Int J Immunopharmacol       Date:  1979

4.  Degranulation of rat mesentery mast cells by antihistamines: influence of ionization.

Authors:  J J Pini; I Vugman
Journal:  Agents Actions       Date:  1978-10

5.  Oxatomide, a new orally active drug which inhibits both the release and the effects of allergic mediators.

Authors:  F Awouters; C J Niemegeers; J Van den Berk; J M Van Neuten; F M Lenaerts; M Borgers; K H Schellekens; A Broeckaert; J De Cree; P A Janssen
Journal:  Experientia       Date:  1977-12-15

6.  Anti-allergic actions of disodium cromoglycate and other drugs known to inhibit cyclic 3',5'-nucleotide phosphodiesterase.

Authors:  W A Taylor; D H Francis; D Sheldon; I M Roitt
Journal:  Int Arch Allergy Appl Immunol       Date:  1974

7.  Inhibitory action of 6-ethyl-3-(1H-tetrazol-5-YL)chromone (AA-344) on IgE, IgGa- or chemical agent-induced histamine release from isolated rat mast cells.

Authors:  T Saijo; Y Ashida; H Kuriki; M Kanno; Y Maki
Journal:  Jpn J Pharmacol       Date:  1979-08

8.  Histamine release from human leukocytes: studies with deuterium oxide, colchicine, and cytochalasin B.

Authors:  E Gillespie; L M Lichtenstein
Journal:  J Clin Invest       Date:  1972-11       Impact factor: 14.808

9.  The interaction of calcium and strontium with phosphatidyl serine in the anaphylactic secretion of histamine.

Authors:  J C Foreman; J L Mongar
Journal:  J Physiol       Date:  1973-04       Impact factor: 5.182

10.  Movement of calcium ions and release of histamine from rat mast cells.

Authors:  N S Ranadive; N Dhanani
Journal:  Int Arch Allergy Appl Immunol       Date:  1980
View more
  5 in total

1.  Suppression of PAF-induced bronchoconstriction in the guinea-pig by oxatomide: mechanism of action.

Authors:  F P Nijkamp; G Folkerts; J R Beetens; F De Clerck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-07       Impact factor: 3.000

2.  Oxatomide protects against degranulation of rat peritoneal mast cells during in vitro challenge with antigen or compound 48/80. Ultrastructural aspects.

Authors:  J Van Reempts; F De Clerck; M Borgers
Journal:  Agents Actions       Date:  1981-05

3.  Virus-induced airway hyperresponsiveness in the guinea-pig: possible involvement of histamine and inflammatory cells.

Authors:  G Folkerts; F De Clerck; I Reijnart; P Span; F P Nijkamp
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

Review 4.  Astemizole. A review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  D M Richards; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-07       Impact factor: 9.546

Review 5.  Oxatomide. A review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  D M Richards; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-03       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.